175 related articles for article (PubMed ID: 27827420)
21. Phosphorylation of MITF by AKT affects its downstream targets and causes TP53-dependent cell senescence.
Wang C; Zhao L; Su Q; Fan X; Wang Y; Gao S; Wang H; Chen H; Chan CB; Liu Z
Int J Biochem Cell Biol; 2016 Nov; 80():132-142. PubMed ID: 27702651
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.
Anghel SI; Correa-Rocha R; Budinska E; Boligan KF; Abraham S; Colombetti S; Fontao L; Mariotti A; Rimoldi D; Ghanem GE; Fisher DE; Lévy F; Delorenzi M; Piguet V
Pigment Cell Melanoma Res; 2012 Jul; 25(4):482-7. PubMed ID: 22594792
[TBL] [Abstract][Full Text] [Related]
23. Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines.
Hertzman Johansson C; Azimi A; Frostvik Stolt M; Shojaee S; Wiberg H; Grafström E; Hansson J; Egyházi Brage S
Melanoma Res; 2013 Oct; 23(5):360-5. PubMed ID: 23921446
[TBL] [Abstract][Full Text] [Related]
24. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.
Kaur A; Webster MR; Marchbank K; Behera R; Ndoye A; Kugel CH; Dang VM; Appleton J; O'Connell MP; Cheng P; Valiga AA; Morissette R; McDonnell NB; Ferrucci L; Kossenkov AV; Meeth K; Tang HY; Yin X; Wood WH; Lehrmann E; Becker KG; Flaherty KT; Frederick DT; Wargo JA; Cooper ZA; Tetzlaff MT; Hudgens C; Aird KM; Zhang R; Xu X; Liu Q; Bartlett E; Karakousis G; Eroglu Z; Lo RS; Chan M; Menzies AM; Long GV; Johnson DB; Sosman J; Schilling B; Schadendorf D; Speicher DW; Bosenberg M; Ribas A; Weeraratna AT
Nature; 2016 Apr; 532(7598):250-4. PubMed ID: 27042933
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
[TBL] [Abstract][Full Text] [Related]
26. [Malignant melanoma and the role of the paradoxal protein Microphthalmia transcription factor].
Denat L; Larue L
Bull Cancer; 2007 Jan; 94(1):81-92. PubMed ID: 17237008
[TBL] [Abstract][Full Text] [Related]
27. Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy.
Wellbrock C; Arozarena I
Pigment Cell Melanoma Res; 2015 Jul; 28(4):390-406. PubMed ID: 25818589
[TBL] [Abstract][Full Text] [Related]
28. Microphthalmia-associated transcription factor suppresses invasion by reducing intracellular GTP pools.
Bianchi-Smiraglia A; Bagati A; Fink EE; Moparthy S; Wawrzyniak JA; Marvin EK; Battaglia S; Jowdy P; Kolesnikova M; Foley CE; Berman AE; Kozlova NI; Lipchick BC; Paul-Rosner LM; Bshara W; Ackroyd JJ; Shewach DS; Nikiforov MA
Oncogene; 2017 Jan; 36(1):84-96. PubMed ID: 27181209
[TBL] [Abstract][Full Text] [Related]
29. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
Goodall J; Carreira S; Denat L; Kobi D; Davidson I; Nuciforo P; Sturm RA; Larue L; Goding CR
Cancer Res; 2008 Oct; 68(19):7788-94. PubMed ID: 18829533
[TBL] [Abstract][Full Text] [Related]
30. The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression.
Schepsky A; Bruser K; Gunnarsson GJ; Goodall J; Hallsson JH; Goding CR; Steingrimsson E; Hecht A
Mol Cell Biol; 2006 Dec; 26(23):8914-27. PubMed ID: 17000761
[TBL] [Abstract][Full Text] [Related]
31. Glucose availability controls ATF4-mediated MITF suppression to drive melanoma cell growth.
Ferguson J; Smith M; Zudaire I; Wellbrock C; Arozarena I
Oncotarget; 2017 May; 8(20):32946-32959. PubMed ID: 28380427
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia and MITF regulate KIT oncogenic properties in melanocytes.
Laugier F; Delyon J; André J; Bensussan A; Dumaz N
Oncogene; 2016 Sep; 35(38):5070-7. PubMed ID: 26973244
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
[TBL] [Abstract][Full Text] [Related]
34. Regulation of MITF stability by the USP13 deubiquitinase.
Zhao X; Fiske B; Kawakami A; Li J; Fisher DE
Nat Commun; 2011 Aug; 2():414. PubMed ID: 21811243
[TBL] [Abstract][Full Text] [Related]
35. MITF and BRN2 contribute to metastatic growth after dissemination of melanoma.
Simmons JL; Pierce CJ; Al-Ejeh F; Boyle GM
Sci Rep; 2017 Sep; 7(1):10909. PubMed ID: 28883623
[TBL] [Abstract][Full Text] [Related]
36. Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor.
Widlund HR; Horstmann MA; Price ER; Cui J; Lessnick SL; Wu M; He X; Fisher DE
J Cell Biol; 2002 Sep; 158(6):1079-87. PubMed ID: 12235125
[TBL] [Abstract][Full Text] [Related]
37. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.
Wellbrock C; Marais R
J Cell Biol; 2005 Aug; 170(5):703-8. PubMed ID: 16129781
[TBL] [Abstract][Full Text] [Related]
38. Pathways from senescence to melanoma: focus on MITF sumoylation.
Leclerc J; Ballotti R; Bertolotto C
Oncogene; 2017 Nov; 36(48):6659-6667. PubMed ID: 28825724
[TBL] [Abstract][Full Text] [Related]
39. A novel role for microphthalmia-associated transcription factor-regulated pigment epithelium-derived factor during melanoma progression.
Dadras SS; Lin RJ; Razavi G; Kawakami A; Du J; Feige E; Milner DA; Loda MF; Granter SR; Detmar M; Widlund HR; Horstmann MA; Fisher DE
Am J Pathol; 2015 Jan; 185(1):252-65. PubMed ID: 25447045
[TBL] [Abstract][Full Text] [Related]
40. Suppression of microphthalmia-associated transcription factor, but not NF-kappa B sensitizes melanoma specific cell death.
Mokhamatam RB; Sahoo BK; Manna SK
Apoptosis; 2016 Aug; 21(8):928-40. PubMed ID: 27325430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]